{"transactions":[{"id":3064577,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-07T20:53:17.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":23142,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) August 5, 2021, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU respresents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":265748,"source":{"system":"sec-edgar","filing":"0001192482-20-000646","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000119248220000646/edgar.xml","form_type":"4"}},{"id":3131942,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-28T20:28:30.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 26, 2021, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU respresents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":242606,"source":{"system":"sec-edgar","filing":"0001192482-20-000406","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000119248220000406/edgar.xml","form_type":"4"}},{"id":3208484,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-16T20:49:18.000Z","date":"2020-03-13","kind":"purchase","acquired":true,"shares":40000,"price":2.28,"value":91200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average purchase price. The highest price at which shares were purchased was $2.35 and the lowest price at which shares were purchased was $2.20. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price for all transactions reported on this Form 4."}],"balance_after":217606,"source":{"system":"sec-edgar","filing":"0001192482-20-000236","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000119248220000236/edgar.xml","form_type":"4"}},{"id":3208483,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-16T20:49:18.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":10000,"price":2.18,"value":21800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. The highest price at which shares were purchased was $2.18 and the lowest price at which shares were purchased was $2.16. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price for all transactions reported on this Form 4."}],"balance_after":177606,"source":{"system":"sec-edgar","filing":"0001192482-20-000236","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000119248220000236/edgar.xml","form_type":"4"}},{"id":3220135,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-09T21:47:56.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award which shall vest on the first anniversary of the date of grant, subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":167606,"source":{"system":"sec-edgar","filing":"0001192482-20-000202","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000119248220000202/edgar.xml","form_type":"4"}},{"id":3367958,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-19T00:45:21.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":11000,"price":4.27,"value":46970.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.25 to $4.28 inclusive."}],"balance_after":147606,"source":{"system":"sec-edgar","filing":"0001209191-19-057051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919119057051/doc4.xml","form_type":"4"}},{"id":3367957,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-19T00:45:21.000Z","date":"2019-11-14","kind":"purchase","acquired":true,"shares":19000,"price":4.6,"value":87400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.5824 to $4.6174 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2)."}],"balance_after":136606,"source":{"system":"sec-edgar","filing":"0001209191-19-057051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919119057051/doc4.xml","form_type":"4"}},{"id":3507328,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-30T20:49:43.000Z","date":"2019-05-28","kind":"grant","acquired":true,"shares":7347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."}],"balance_after":7347,"derivative":{"exercise_price":13.43,"expiration_date":"2029-05-27","underlying":"Common Stock","underlying_shares":7347},"source":{"system":"sec-edgar","filing":"0001209191-19-033452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919119033452/doc4.xml","form_type":"4"}},{"id":3507327,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-30T20:49:43.000Z","date":"2019-05-28","kind":"grant","acquired":true,"shares":5584,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":117606,"source":{"system":"sec-edgar","filing":"0001209191-19-033452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919119033452/doc4.xml","form_type":"4"}},{"id":3548597,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-25T21:37:44.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":1584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award.  The RSUs will vest on the earlier of July 26, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":112022,"source":{"system":"sec-edgar","filing":"0001209191-19-026015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919119026015/doc4.xml","form_type":"4"}},{"id":3872427,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Grant (Right to Buy)","published_at":"2018-07-05T20:32:52.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":10959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The performance criterion for vesting of this option was met upon the closing of the Issuer's initial public offering.  One twelfth (1/12th) of the shares subject to the option vested or shall vest monthly commencing on March 16, 2018, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":10959,"derivative":{"exercise_price":5.22,"expiration_date":"2028-04-25","underlying":"Common Stock","underlying_shares":10959},"source":{"system":"sec-edgar","filing":"0001209191-18-041640","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919118041640/doc4.xml","form_type":"4"}},{"id":3872426,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series G Covertible Preferred Stock","published_at":"2018-07-05T20:32:52.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":1506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1506},"source":{"system":"sec-edgar","filing":"0001209191-18-041640","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919118041640/doc4.xml","form_type":"4"}},{"id":3872425,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F Covertible Preferred Stock","published_at":"2018-07-05T20:32:52.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":9525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9525},"source":{"system":"sec-edgar","filing":"0001209191-18-041640","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919118041640/doc4.xml","form_type":"4"}},{"id":3872424,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E Covertible Preferred Stock","published_at":"2018-07-05T20:32:52.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":15342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15342},"source":{"system":"sec-edgar","filing":"0001209191-18-041640","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919118041640/doc4.xml","form_type":"4"}},{"id":3872423,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Covertible Preferred Stock","published_at":"2018-07-05T20:32:52.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":8483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8483},"source":{"system":"sec-edgar","filing":"0001209191-18-041640","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919118041640/doc4.xml","form_type":"4"}},{"id":3872422,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T20:32:52.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":1506,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."}],"balance_after":110438,"source":{"system":"sec-edgar","filing":"0001209191-18-041640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919118041640/doc4.xml","form_type":"4"}},{"id":3872421,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T20:32:52.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":9525,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."}],"balance_after":108932,"source":{"system":"sec-edgar","filing":"0001209191-18-041640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919118041640/doc4.xml","form_type":"4"}},{"id":3872420,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T20:32:52.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":15342,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."}],"balance_after":99407,"source":{"system":"sec-edgar","filing":"0001209191-18-041640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919118041640/doc4.xml","form_type":"4"}},{"id":3872419,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T20:32:52.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":8483,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering."}],"balance_after":84065,"source":{"system":"sec-edgar","filing":"0001209191-18-041640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227636/000120919118041640/doc4.xml","form_type":"4"}},{"id":4023571,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T13:18:11.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":10.62,"value":53100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, which provided for vesting in full on the earlier of June 13, 2018 and the date of the annual stockholder meeting following June 13, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":13.38,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001235802-18-000019","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000019/primary_doc.xml","form_type":"4"}},{"id":4023570,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T13:18:11.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":5.74,"value":57400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, which provided for vesting in full on the earlier of June 14, 2017 and the date of the annual stockholder meeting following June 14, 2016, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":18.26,"expiration_date":"2026-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001235802-18-000019","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000019/primary_doc.xml","form_type":"4"}},{"id":4023569,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T13:18:11.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":188800,"price":12.64,"value":2386432.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, which provided for vesting in 48 equal monthly installments commencing on December 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":11.36,"expiration_date":"2024-12-16","underlying":"Common Stock","underlying_shares":188800},"source":{"system":"sec-edgar","filing":"0001235802-18-000019","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000019/primary_doc.xml","form_type":"4"}},{"id":4023568,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T13:18:11.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":34510,"price":22.76,"value":785447.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which was fully vested on January 1, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":1.24,"expiration_date":"2023-03-19","underlying":"Common Stock","underlying_shares":34510},"source":{"system":"sec-edgar","filing":"0001235802-18-000019","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000019/primary_doc.xml","form_type":"4"}},{"id":4023567,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T13:18:11.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":28439,"price":23.24,"value":660922.36,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which was fully vested on December 31, 2015, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":0.76,"expiration_date":"2022-02-08","underlying":"Common Stock","underlying_shares":28439},"source":{"system":"sec-edgar","filing":"0001235802-18-000019","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000019/primary_doc.xml","form_type":"4"}},{"id":4023566,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T13:18:11.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":39563,"price":22.64,"value":895706.32,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which was fully vested on January 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2020-03-24","underlying":"Common Stock","underlying_shares":39563},"source":{"system":"sec-edgar","filing":"0001235802-18-000019","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000019/primary_doc.xml","form_type":"4"}},{"id":4023565,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-03-01T13:18:11.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":291743,"price":24,"value":7001832.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001235802-18-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580218000019/primary_doc.xml","form_type":"4"}},{"id":4139130,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-12-07T16:37:57.000Z","date":"2017-12-07","kind":"sale","acquired":false,"shares":101319,"price":23.85,"value":2416458.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."}],"balance_after":291743,"source":{"system":"sec-edgar","filing":"0001686266-17-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000168626617000019/primary_doc.xml","form_type":"4"}},{"id":4191992,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-10-04T16:43:54.000Z","date":"2017-10-04","kind":"sale","acquired":false,"shares":20000,"price":20.1549,"value":403098.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.10 to $20.195, inclusive.  The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."}],"balance_after":393062,"source":{"system":"sec-edgar","filing":"0001235802-17-000156","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000156/primary_doc.xml","form_type":"4"}},{"id":4191991,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-10-04T16:43:54.000Z","date":"2017-10-04","kind":"sale","acquired":false,"shares":10000,"price":19.6611,"value":196611.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.60 to $19.725, inclusive.  The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."}],"balance_after":413062,"source":{"system":"sec-edgar","filing":"0001235802-17-000156","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000156/primary_doc.xml","form_type":"4"}},{"id":4191990,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-10-04T16:43:54.000Z","date":"2017-10-03","kind":"sale","acquired":false,"shares":6028,"price":19.165,"value":115526.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.385, inclusive.  The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."}],"balance_after":423062,"source":{"system":"sec-edgar","filing":"0001235802-17-000156","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000156/primary_doc.xml","form_type":"4"}},{"id":4191989,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-10-04T16:43:54.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":3972,"price":19.1,"value":75865.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."}],"balance_after":429090,"source":{"system":"sec-edgar","filing":"0001235802-17-000156","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000156/primary_doc.xml","form_type":"4"}},{"id":4282114,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-14T16:20:22.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the earlier to occur of June 13, 2018 and the date of the Company's annual meeting of stockholders immediately following June 13, 2017, subject to the Reporting Person's continued service with the Company through the applicable vesting date."}],"balance_after":5000,"derivative":{"exercise_price":13.38,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001235802-17-000081","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000081/primary_doc.xml","form_type":"4"}},{"id":4282113,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-06-14T16:20:22.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 2,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."}],"balance_after":433062,"source":{"system":"sec-edgar","filing":"0001235802-17-000081","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000081/primary_doc.xml","form_type":"4"}},{"id":4488078,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-01-18T16:12:34.000Z","date":"2017-01-13","kind":"sale","acquired":false,"shares":14019,"price":20.1383,"value":282318.8277,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.11 to $20.22, inclusive.  The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":430562,"source":{"system":"sec-edgar","filing":"0001235802-17-000017","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000017/primary_doc.xml","form_type":"4"}},{"id":4493919,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-01-10T16:43:17.000Z","date":"2017-01-10","kind":"sale","acquired":false,"shares":4842,"price":19.1001,"value":92482.6842,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.11, inclusive.  The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":444581,"source":{"system":"sec-edgar","filing":"0001235802-17-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000012/primary_doc.xml","form_type":"4"}},{"id":4493918,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-01-10T16:43:17.000Z","date":"2017-01-09","kind":"sale","acquired":false,"shares":5000,"price":19.1194,"value":95597.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.12, inclusive.  The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":449423,"source":{"system":"sec-edgar","filing":"0001235802-17-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000012/primary_doc.xml","form_type":"4"}},{"id":4498271,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-01-05T16:24:49.000Z","date":"2017-01-04","kind":"sale","acquired":false,"shares":158,"price":19.1,"value":3017.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":454423,"source":{"system":"sec-edgar","filing":"0001235802-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000003/primary_doc.xml","form_type":"4"}},{"id":4498270,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-01-05T16:24:49.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":20000,"price":18.7364,"value":374728.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.68 to $18.88, inclusive.  The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":454581,"source":{"system":"sec-edgar","filing":"0001235802-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580217000003/primary_doc.xml","form_type":"4"}},{"id":4527013,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-12-09T17:27:10.000Z","date":"2016-12-07","kind":"sale","acquired":false,"shares":1749,"price":19,"value":33231.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":475581,"source":{"system":"sec-edgar","filing":"0001686266-16-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000168626616000005/primary_doc.xml","form_type":"4"}},{"id":4527012,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-12-09T17:27:10.000Z","date":"2016-12-07","kind":"sale","acquired":false,"shares":919,"price":19.1,"value":17552.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":476330,"source":{"system":"sec-edgar","filing":"0001686266-16-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000168626616000005/primary_doc.xml","form_type":"4"}},{"id":4527011,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-12-09T17:27:10.000Z","date":"2016-12-07","kind":"sale","acquired":false,"shares":2332,"price":19.2,"value":44774.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":477249,"source":{"system":"sec-edgar","filing":"0001686266-16-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000168626616000005/primary_doc.xml","form_type":"4"}},{"id":4529840,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-12-07T16:05:50.000Z","date":"2016-12-06","kind":"sale","acquired":false,"shares":4348,"price":18.7,"value":81307.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":479581,"source":{"system":"sec-edgar","filing":"0001235802-16-000327","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580216000327/primary_doc.xml","form_type":"4"}},{"id":4529839,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-12-07T16:05:50.000Z","date":"2016-12-05","kind":"sale","acquired":false,"shares":652,"price":18.7,"value":12192.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":483929,"source":{"system":"sec-edgar","filing":"0001235802-16-000327","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580216000327/primary_doc.xml","form_type":"4"}},{"id":4529838,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-12-07T16:05:50.000Z","date":"2016-12-05","kind":"sale","acquired":false,"shares":10000,"price":18.5006,"value":185006.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.31 to $18.69, inclusive.  The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":484581,"source":{"system":"sec-edgar","filing":"0001235802-16-000327","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580216000327/primary_doc.xml","form_type":"4"}},{"id":4541009,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-11-28T16:22:31.000Z","date":"2016-11-23","kind":"sale","acquired":false,"shares":5000,"price":19,"value":95000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":494581,"source":{"system":"sec-edgar","filing":"0001235802-16-000324","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580216000324/primary_doc.xml","form_type":"4"}},{"id":4542922,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-11-23T16:04:55.000Z","date":"2016-11-22","kind":"sale","acquired":false,"shares":5000,"price":18.7,"value":93500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":499581,"source":{"system":"sec-edgar","filing":"0001235802-16-000323","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580216000323/primary_doc.xml","form_type":"4"}},{"id":4548632,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-11-18T16:54:05.000Z","date":"2016-11-18","kind":"sale","acquired":false,"shares":5000,"price":18.3,"value":91500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":504581,"source":{"system":"sec-edgar","filing":"0001235802-16-000321","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580216000321/primary_doc.xml","form_type":"4"}},{"id":4548631,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-11-18T16:54:05.000Z","date":"2016-11-17","kind":"sale","acquired":false,"shares":5000,"price":18.3,"value":91500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":509581,"source":{"system":"sec-edgar","filing":"0001235802-16-000321","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580216000321/primary_doc.xml","form_type":"4"}},{"id":4583279,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-10-06T16:16:56.000Z","date":"2016-10-05","kind":"sale","acquired":false,"shares":30000,"price":22.2591,"value":667773.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.25 to $22.50, inclusive.  The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":514581,"source":{"system":"sec-edgar","filing":"0001235802-16-000313","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580216000313/primary_doc.xml","form_type":"4"}},{"id":4610913,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":147316,"kind":"person","name":"Farley Brian E","position":1,"cik":"0001306117","reported_name":"Farley Brian E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2016-09-06T16:17:45.000Z","date":"2016-09-02","kind":"sale","acquired":false,"shares":11078,"price":18.6225,"value":206300.055,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.60 to $18.90, inclusive.  The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":544581,"source":{"system":"sec-edgar","filing":"0001235802-16-000299","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374128/000123580216000299/primary_doc.xml","form_type":"4"}}]}